Trial Profile
The Controlled Trial of Apremilast for Rheumatoid Arthritis Treatment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Apremilast (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms CARAT
- 28 Aug 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 06 Mar 2014 Planned end date changed from 1 Oct 2013 to 1 Oct 2014 as reported by ClinicalTrials.gov record.
- 20 Sep 2013 Planned end date changed from 1 Jun 2013 to 1 Oct 2013 as reported by ClinicalTrials.gov.